Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Podcast Nov 2020 Ethics Talk: Managing Health Care AI “Megarisks” Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves. Case and Commentary Nov 2020 What Is an Ethically Informed Approach to Managing Patient Safety Risk During Discharge Planning? John C. West, JD, MA Patients leaving against medical advice draw attention to intersections of tort law, federal and state regulations, and clinical ethics. AMA J Ethics. 2020;22(11):E919-923. doi: 10.1001/amajethics.2020.919. AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. State of the Art and Science Nov 2020 How Might Artificial Intelligence Applications Impact Risk Management? John Banja, PhD AI models might advance human welfare in unprecedented ways, but progress will not occur without substantial risks that will have to be managed. AMA J Ethics. 2020;22(11):E945-951. doi: 10.1001/amajethics.2020.945. Medicine and Society Sep 2020 Designing Nudges for Success in Health Care Joseph D. Harrison, MBDS and Mitesh S. Patel, MD, MBA Nudges can improve patient outcomes, but decisions need to be made about where they fit in the flow of health service delivery. AMA J Ethics. 2020;22(9):E796-801. doi: 10.1001/amajethics.2020.796. Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary May 2005 End of Life and Sanctity of Life, Commentary 1 Rabbi Edward Reichman, MD Virtual Mentor. 2005;7(5):342-351. doi: 10.1001/virtualmentor.2005.7.5.ccas2-0505. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Podcast Nov 2020 Ethics Talk: Managing Health Care AI “Megarisks” Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves.
Case and Commentary Nov 2020 What Is an Ethically Informed Approach to Managing Patient Safety Risk During Discharge Planning? John C. West, JD, MA Patients leaving against medical advice draw attention to intersections of tort law, federal and state regulations, and clinical ethics. AMA J Ethics. 2020;22(11):E919-923. doi: 10.1001/amajethics.2020.919.
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
State of the Art and Science Nov 2020 How Might Artificial Intelligence Applications Impact Risk Management? John Banja, PhD AI models might advance human welfare in unprecedented ways, but progress will not occur without substantial risks that will have to be managed. AMA J Ethics. 2020;22(11):E945-951. doi: 10.1001/amajethics.2020.945.
Medicine and Society Sep 2020 Designing Nudges for Success in Health Care Joseph D. Harrison, MBDS and Mitesh S. Patel, MD, MBA Nudges can improve patient outcomes, but decisions need to be made about where they fit in the flow of health service delivery. AMA J Ethics. 2020;22(9):E796-801. doi: 10.1001/amajethics.2020.796.
Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary May 2005 End of Life and Sanctity of Life, Commentary 1 Rabbi Edward Reichman, MD Virtual Mentor. 2005;7(5):342-351. doi: 10.1001/virtualmentor.2005.7.5.ccas2-0505.